Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03307356 · ClinicalTrials.gov registry record · NA
The University of Pennsylvania Uterus Transplant for Uterine Factor Infertility Trial
A NA study of Mayer Rokitansky Kuster Hauser Syndrome and Uterine Factor Infertility, sponsored by University of Pennsylvania.
- Active
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT03307356: Active NA study of Mayer Rokitansky Kuster Hauser Syndrome and Uterine Factor Infertility, sponsored by University of Pennsylvania.
NCT03307356 is a NA study of Mayer Rokitansky Kuster Hauser Syndrome and Uterine Factor Infertility that is active but no longer recruiting, run by University of Pennsylvania. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03307356, a NA study of Mayer Rokitansky Kuster Hauser Syndrome and Uterine Factor Infertility, is active but no longer recruiting, sponsored by University of Pennsylvania.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
Options for childbearing are limited for the thousands of women in the United States who suffer from absolute uterine factor infertility. Uterine transplantation is an emerging treatment that provides hope for these individuals. In the Penn UNTIL trial, the investigators plan to perform uterus transplants on five women who will ultimately undergo embryo transfer, pregnancy, delivery, and then transplant hysterectomy. This trial is accepting women in need of a transplant and also women who are interested in being a live donor. For more information please visit: https://clinicalresearch.itmat.upenn.edu/clinicaltrial/4821/congenital-abnormalitiesfemale-infertility-penn-ut/
Primary Outcome
Uterus remains in recipient with no complications (i.e. infection or rejection) or any complications that did arise could be successfully treated.
Conditions Studied
Interventions
- OTHER Uterine Transplant
Study Locations (1)
Pennsylvania
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2018-01-10 |
| Est. Completion | 2029-07-01 |
| Phase | NA |
What the registry record for NCT03307356 still lists
NCT03307356 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 4 conditions, with Mayer Rokitansky Kuster Hauser Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Uterine Transplant is the first listed.
NCT03307356 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT03307356 about?
NCT03307356 is a clinical study titled "The University of Pennsylvania Uterus Transplant for Uterine Factor Infertility Trial". Options for childbearing are limited for the thousands of women in the United States who suffer from absolute uterine factor infertility. Uterine transplantation is an emerging treatment that provides hope for these individuals. In the Penn UNTIL trial, the investigators plan to perform uterus tran...
What is the current status of trial NCT03307356?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2018-01-10. Estimated completion is 2029-07-01.
What conditions does trial NCT03307356 study?
This clinical trial studies the following conditions: Mayer Rokitansky Kuster Hauser Syndrome, Uterine Factor Infertility, Uterine Agenesis, Infertility, Female, of Uterine Origin.
What interventions are being tested in trial NCT03307356?
The interventions under investigation include: Uterine Transplant (OTHER).
Who is sponsoring clinical trial NCT03307356?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03307356 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Mayer Rokitansky Kuster Hauser Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03307356's enrollment target sits among peer trials
10 1927th of 2000 higher than 26 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI